We are live on ! Find out more
AIM

Avanda Investment Management Portfolio holdings

AUM $63.1M
1-Year Est. Return 2.43%
This Fund
S&P 500
This Quarter Est. Return
+9.76%
1 Year Est. Return
+2.43%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$745M
AUM Growth
-$280M
Cap. Flow
-$361M
Cap. Flow %
-48.43%
Top 10 Hldgs %
58.6%
Holding
57
New
22
Increased
1
Reduced
27
Closed
7

Top Buys

Rank Stock Value
1
DHR icon
Danaher
DHR
+$11.8M
2
MCO icon
Moody's
MCO
+$9.32M
3
CTAS icon
Cintas
CTAS
+$8.92M
4
PAYX icon
Paychex
PAYX
+$8.8M
5
TDG icon
TransDigm Group
TDG
+$8.17M

Sector Composition

Rank Sector Weight
1 Technology 18.82%
2 Consumer Discretionary 12.19%
3 Financials 9.98%
4 Communication Services 9.03%
5 Healthcare 7.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PAYX icon
26
Paychex
PAYX
$42.7B
$8.91M 1.19%
+72,520
New +$8.8M
COST icon
27
Costco
COST
$420B
$8.81M 1.18%
12,019
-24,796
-67% -$17.7M
WAT icon
28
Waters Corp
WAT
$40.3B
$8.23M 1.1%
+23,900
New +$7.86M
LIN icon
29
Linde
LIN
$226B
$8.2M 1.1%
17,666
-57,226
-76% -$24.8M
SHW icon
30
Sherwin-Williams
SHW
$88B
$7.99M 1.07%
23,015
-61,211
-73% -$19.5M
SPGI icon
31
S&P Global
SPGI
$121B
$7.72M 1.04%
+18,151
New +$7.87M
XOM icon
32
ExxonMobil
XOM
$655B
$7M 0.94%
+60,200
New +$6.3M
EW icon
33
Edwards Lifesciences
EW
$53B
$6.86M 0.92%
+71,800
New +$6.03M
APH icon
34
Amphenol
APH
$209B
$6.82M 0.91%
+118,176
New +$6.19M
SNPS icon
35
Synopsys
SNPS
$80B
$6.77M 0.91%
+11,854
New +$6.52M
FISV
36
Fiserv Inc
FISV
$27.5B
$6.75M 0.91%
+42,257
New +$6.15M
ROP icon
37
Roper Technologies
ROP
$39.5B
$6.7M 0.9%
+11,955
New +$6.52M
EFX icon
38
Equifax
EFX
$21.4B
$6.42M 0.86%
+23,991
New +$6.11M
IDXX icon
39
Idexx Laboratories
IDXX
$46.9B
$6.39M 0.86%
+11,835
New +$6.47M
PTC icon
40
PTC
PTC
$16.4B
$5.87M 0.79%
+31,089
New +$5.6M
CVX icon
41
Chevron
CVX
$378B
$5.72M 0.77%
+36,268
New +$5.47M
CDNS icon
42
Cadence Design Systems
CDNS
$93.3B
$5.62M 0.75%
+18,070
New +$5.34M
FDS icon
43
Factset
FDS
$10.2B
$5.48M 0.74%
+12,057
New +$5.62M
ZTS icon
44
Zoetis
ZTS
$29.9B
$5.09M 0.68%
+30,104
New +$5.64M
TDCX
45
DELISTED
TDCX Inc. American Depositary Shares, each representing one Class A ordinary share
TDCX
$3.53M 0.47%
492,416
-276,984
-36% -$1.82M
SN icon
46
SharkNinja
SN
$26.1B
$2.57M 0.34%
41,198
-26,170
-39% -$1.38M
INDA icon
47
iShares MSCI India ETF
INDA
$6.61B
$2.3M 0.31%
44,550
-601,498
-93% -$30.3M
HDB icon
48
HDFC Bank
HDB
$121B
$1.82M 0.24%
+65,000
New +$1.84M
PDD icon
49
Pinduoduo
PDD
$132B
$661K 0.09%
+5,686
New +$745K
GRAB icon
50
Grab
GRAB
$14.8B
$141K 0.02%
45,000
-154,231
-77% -$495K

Similar funds

Avanda Investment Management's Q1 2024 Portfolio in Review

As of Q1 2024, Avanda Investment Management held 57 positions worth $745M, down 27% from $1.03B the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Avanda Investment Management withdrew a net $361M in Q1 2024, closing 7 positions and reducing 27 holdings. Its most notable exit was iShares MSCI Mexico ETF, an estimated $7.37M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Avanda Investment Management opened a new position in Danaher worth $12M.

  • Avanda Investment Management's largest Q1 2024 buy was Danaher: 48,235 shares worth $12M.
  • Avanda Investment Management added most to iShares MSCI Saudi Arabia ETF in Q1 2024, an estimated $640K increase.
  • Avanda Investment Management's biggest Q1 2024 reduction was Meta Platforms (Facebook), cutting an estimated $42.2M.
  • Avanda Investment Management fully exited iShares MSCI Mexico ETF in Q1 2024, selling an estimated $7.37M.
  • Avanda Investment Management's ten largest holdings make up 59% of its $745M portfolio in Q1 2024.
  • Avanda Investment Management opened 22 new positions and closed 7 in Q1 2024.
  • Avanda Investment Management's portfolio value fell 27% quarter-over-quarter to $745M.

Based on Avanda Investment Management's 13F filing for Q1 2024, filed 14 May 2024.